Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Lymphangiogenesis factors: a target for therapy?

Arjan W. Griffioen

Blood (2009) 113 (18): 4135–4136.

https://doi.org/10.1182/blood-2009-01-198879

Published: 2009

Journal Articles

Angiostatic activity of the antitumor cytokine interleukin-21

Karolien Castermans, Sebastien P. Tabruyn, Rong Zeng, Judy R. van Beijnum, Cheryl Eppolito, Warren J. Leonard, Protul A. Shrikant, Arjan W. Griffioen

Blood (2008) 112 (13): 4940–4947.

https://doi.org/10.1182/blood-2007-09-113878

Published: 2008

Includes: Supplemental data

Journal Articles

New entry for angiostatic cancer treatment

Arjan W. Griffioen

Blood (2008) 111 (4): 1755–1756.

https://doi.org/10.1182/blood-2008-01-130336

Published: 2008

Journal Articles

Galectins in the tumor endothelium: opportunities for combined cancer therapy

Victor L. J. L. Thijssen, Françoise Poirier, Linda G. Baum, Arjan W. Griffioen

Blood (2007) 110 (8): 2819–2827.

https://doi.org/10.1182/blood-2007-03-077792

Published: 2007

Journal Articles

Gene expression of tumor angiogenesis dissected: specific targeting of colon cancer angiogenic vasculature

Judy R. van Beijnum, Ruud P. Dings, Edith van der Linden, Bernadette M. M. Zwaans, Frans C. S. Ramaekers, Kevin H. Mayo, Arjan W. Griffioen

Blood (2006) 108 (7): 2339–2348.

https://doi.org/10.1182/blood-2006-02-004291

Published: 2006

Includes: Supplemental data

Journal Articles

Bactericidal/permeability-increasing protein (BPI) inhibits angiogenesis via induction of apoptosis in vascular endothelial cells

Daisy W. J. van der Schaft, Elly A. H. Toebes, Judith R. Haseman, Kevin H. Mayo, Arjan W. Griffioen

Blood (2000) 96 (1): 176–181.

https://doi.org/10.1182/blood.V96.1.176

Published: 2000

Journal Articles

CD44 Is Involved in Tumor Angiogenesis; an Activation Antigen on Human Endothelial Cells

Arjan W. Griffioen, Marieke J.H. Coenen, Cora A. Damen, Sandra M.M. Hellwig, David H.J. van Weering, Wim Vooys, Geert H. Blijham, Gerard Groenewegen

Blood (1997) 90 (3): 1150–1159.

https://doi.org/10.1182/blood.V90.3.1150

Published: 1997

NARROW

Lymphangiogenesis factors: a target for therapy?

Angiostatic activity of the antitumor cytokine interleukin-21

New entry for angiostatic cancer treatment

Galectins in the tumor endothelium: opportunities for combined cancer therapy

Gene expression of tumor angiogenesis dissected: specific targeting of colon cancer angiogenic vasculature

Bactericidal/permeability-increasing protein (BPI) inhibits angiogenesis via induction of apoptosis in vascular endothelial cells

CD44 Is Involved in Tumor Angiogenesis; an Activation Antigen on Human Endothelial Cells

Email alerts

ASH Publications

American Society of Hematology

Lymphangiogenesis factors: a target for therapy?

Angiostatic activity of the antitumor cytokine interleukin-21

New entry for angiostatic cancer treatment

Galectins in the tumor endothelium: opportunities for combined cancer therapy

Gene expression of tumor angiogenesis dissected: specific targeting of colon cancer angiogenic vasculature

Bactericidal/permeability-increasing protein (BPI) inhibits angiogenesis via induction of apoptosis in vascular endothelial cells

CD44 Is Involved in Tumor Angiogenesis; an Activation Antigen on Human Endothelial Cells

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only